Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
BABA-W
09988
| (Q3)Oct 31, 2025 | (Q2)Jul 31, 2025 | (Q1)Apr 30, 2025 | (FY)Jan 31, 2025 | (Q4)Jan 31, 2025 | (Q3)Oct 31, 2024 | (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 211.51%109.48K | -177.31%-11.62K | 3,326.65%60.31K | -132.44%-202.84K | -208.15%-117.83K | -1,638.24%-98.18K | 106.49%15.03K | -104.56%-1.87K | 19.92%-87.27K | 194.68%108.95K |
| Net income from continuing operations | 35.90%-43.11K | -188.54%-304.9K | 2.15%96.58K | 49.89%-314.98K | -78.30%-236.61K | 72.16%-67.25K | -31.11%-105.67K | 154.40%94.55K | -124.16%-628.62K | 13.77%-132.7K |
| Operating gains losses | ---- | ---- | ---- | -300.75%-104.83K | ---112.83K | --118.67K | ---120.92K | --10.24K | -64.13%52.22K | ---- |
| Depreciation and amortization | 15.54%2.69K | 15.64%2.69K | 82.18%4.24K | 38.52%12.9K | 154.12%5.92K | 0.00%2.33K | 0.00%2.33K | 0.00%2.33K | 0.00%9.31K | 0.00%2.33K |
| Asset impairment expenditure | ---- | ---- | ---- | 28.25%264.33K | ---- | ---- | ---- | ---- | -43.57%206.11K | ---- |
| Unrealized gains and losses of investment securities | -370.37%-37.53K | -63.82%19.3K | 98.59%-635 | -80.21%30.42K | 109.63%8.18K | -83.10%13.88K | 681.56%53.34K | -127.15%-44.97K | 1,528.51%153.69K | 26.31%-84.93K |
| Remuneration paid in stock | --13.41K | --222.76K | --0 | -87.42%14.58K | --0 | --0 | --0 | --14.58K | --115.83K | --0 |
| Deferred tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non cashItems | 16.51%-100.89K | -15.59%102.16K | 35.98%-77.32K | -134.06%-110.13K | 10,872.16%10.45K | -154.42%-120.84K | 47,549.21%121.03K | -42,326.92%-120.77K | 87.13%-47.05K | 99.97%-97 |
| Change In working capital | 537.89%196.9K | -62.44%24.39K | -11.23%37.44K | -90.49%4.87K | -186.74%-57.26K | -154.13%-44.97K | 144.98%64.92K | -9.27%42.18K | 12.75%51.24K | 193.06%66.02K |
| -Change in receivables | -2.60%-23.53K | 883.58%21.21K | 178.92%29.74K | -312.43%-61.1K | -324.42%-50.98K | -350.33%-22.93K | 138.54%2.16K | -71.34%10.66K | 196.75%28.76K | 51.54%-12.01K |
| -Change in prepaid assets | -0.47%-59.81K | -162.60%-9.43K | -28.85%6.74K | 184.06%17.6K | 22.45%52.6K | -297.82%-59.54K | 137.41%15.06K | 117.64%9.48K | -1,360.14%-20.93K | 8,207.93%42.95K |
| -Change in payables and accrued expense | 582.87%256.09K | -73.57%12.61K | -95.64%962 | 11.44%48.37K | -267.84%-58.88K | -14.42%37.5K | 148.43%47.71K | -65.02%22.04K | -40.95%43.41K | 175.16%35.08K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 211.51%109.48K | -177.31%-11.62K | 3,326.65%60.31K | -132.44%-202.84K | -208.15%-117.83K | -1,638.24%-98.18K | 106.49%15.03K | -104.56%-1.87K | 19.92%-87.27K | 194.68%108.95K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -897.68%-363.84K | -26.06%-179.32K | -161.28%-62.09K | -206.28%-721.65K | -2,446.07%-519.17K | 13.71%-36.47K | -12.44%-142.25K | 48.85%-23.76K | 0.88%-235.62K | -134.49%-20.39K |
| Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Net investment purchase and sale | --0 | --0 | --0 | 0.17%36.88K | -100.00%1 | --19.91K | --0 | --16.97K | -27.59%36.82K | 140.59%36.82K |
| Net other investing changes | -545.35%-363.84K | -26.06%-179.32K | -52.42%-62.09K | -178.42%-758.54K | -807.50%-519.17K | -33.39%-56.38K | -12.44%-142.25K | 12.32%-40.73K | 38.58%-272.44K | -1.83%-57.21K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -897.68%-363.84K | -26.06%-179.32K | -161.28%-62.09K | -206.28%-721.65K | -2,446.07%-519.17K | 13.71%-36.47K | -12.44%-142.25K | 48.85%-23.76K | 0.88%-235.62K | -134.49%-20.39K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 85.81%882.43K | 6,972.94%346.86K | -105.71%-4.87K | 307.37%967.38K | 1,044.35%402.26K | 18,407.67%474.9K | -98.28%4.9K | 3,383.53%85.31K | 259.16%237.47K | -157.64%-42.6K |
| Net issuance payments of debt | -20.95%-3.14K | -21.07%-3.14K | -87.78%-4.87K | 73.16%-13.52K | 86.53%-5.74K | -0.12%-2.6K | -0.04%-2.6K | 0.15%-2.59K | -385.25%-50.38K | -1,541.50%-42.6K |
| Net common stock issuance | 73.80%829.9K | 4,566.67%350K | --0 | 240.77%980.9K | --408K | --477.5K | -97.39%7.5K | --87.9K | 276.27%287.85K | --0 |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---14.9K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 83.00%869.09K | 7,244.84%360.19K | -105.71%-4.87K | 307.37%967.38K | 1,044.35%402.26K | 18,407.67%474.9K | -98.28%4.9K | 3,383.53%85.31K | 259.16%237.47K | -157.64%-42.6K |
| Net cash flow | ||||||||||
| Beginning cash position | 1,672.57%284.16K | -16.95%114.91K | 54.50%121.56K | -52.05%78.68K | 988.86%356.29K | -80.74%16.03K | -11.32%138.36K | -52.05%78.68K | -63.10%164.1K | -77.61%32.72K |
| Current changes in cash | 80.67%614.73K | 238.36%169.25K | -111.14%-6.65K | 150.19%42.88K | -610.74%-234.73K | 773.68%340.26K | -68.05%-122.32K | 838.10%59.68K | 69.55%-85.42K | 155.84%45.96K |
| End cash Position | 152.29%898.89K | 1,672.57%284.16K | -16.95%114.91K | 54.50%121.56K | 54.50%121.56K | 988.86%356.29K | -80.74%16.03K | -11.32%138.36K | -52.05%78.68K | -52.05%78.68K |
| Free cash from | 211.51%109.48K | -177.31%-11.62K | 3,326.65%60.31K | -132.44%-202.84K | -208.15%-117.83K | -1,638.24%-98.18K | 106.49%15.03K | -104.56%-1.87K | 19.92%-87.27K | 194.68%108.95K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.